Advanced Therapies

Council of Europe proposes regulatory framework for human organs manipulated ex situ

The European Committee on Organs, Tissues and Cells (CD-P-TO) of the Council of Europe, with Secretariat support from the European Directorate for the Quality...

Moderna’s strategic vision for 2024: expanding mRNA medicine

Moderna, a biotechnology company specialising in mRNA medicines and vaccines, entered 2024 with 45 therapeutic and vaccine programmes, including nine in late-stage development. The...
spot_imgspot_img